Role of phosphoinositide 3-kinase p110δ in TLR4- and TLR9-mediated B cell cytokine production and differentiation

Molecular Immunology

Volumn 46, Issue 10, 2009, Pages 1970-1978

  Dil, Nyla ^a   Marshall, Aaron J ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

B lymphocyte; CpG; Cytokines; Immunoglobulins; LPS; Phosphoinositide 3 kinase; Plasma cells; TLR4; TLR9; Toll like receptor

Indexed keywords

2 (6 AMINO 9 PURINYLMETHYL) 5 METHYL 3 (2 METHYLPHENYL) 3H QUINAZOLIN 4 ONE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 6; ISOPROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE P110DELTA; PROTEIN P110; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ALLERGY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; INFLAMMATION; LIGAND BINDING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MALE; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOKINES; IMMUNOGLOBULIN CLASS SWITCHING; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; OLIGODEOXYRIBONUCLEOTIDES; PLASMA CELLS; PROTEIN KINASE INHIBITORS; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9;

MUS;

EID: 67349280350     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.03.010     Document Type: Article

References (52)

1. Aksoy E., Vanden Berghe W., Detienne S., Amraoui Z., Fitzgerald K.A., Haegeman G., Goldman M., and Willems F. Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-kappa B activation and IFN-beta synthesis downstream of Toll-like receptor 3 and 4. Eur. J. Immunol. 35 (2005) 2200-2209
2. Barr T.A., Brown S., Ryan G., Zhao J., and Gray D. TLR-mediated stimulation of APC: distinct cytokine responses of B cells and dendritic cells. Eur. J. Immunol. 37 (2007) 3040-3053
3. Bernasconi N.L., Onai N., and Lanzavecchia A. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 101 (2003) 4500-4504
4. Clayton E., Bardi G., Bell S.E., Chantry D., Downes C.P., Gray A., Humphries L.A., Rawlings D., Reynolds H., Vigorito E., and Turner M. A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation. J. Exp. Med. 196 (2002) 753-763
5. Coutinho A., Gronowicz E., Bullock W.W., and Moller G. Mechanism of thymus-independent immunocyte triggering. Mitogenic activation of B cells results in specific immune responses. J. Exp. Med. 139 (1974) 74-92
6. Diaz-Guerra M.J., Castrillo A., Martin-Sanz P., and Bosca L. Negative regulation by phosphatidylinositol 3-kinase of inducible nitric oxide synthase expression in macrophages. J. Immunol. 162 (1999) 6184-6190
7. Dobrovolskaia M.A., Medvedev A.E., Thomas K.E., Cuesta N., Toshchakov V., Ren T., Cody M.J., Michalek S.M., Rice N.R., and Vogel S.N. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR homotolerance versus heterotolerance on NF-kappa B signaling pathway components. J. Immunol. 170 (2003) 508-519
8. Ehlers M., Fukuyama H., McGaha T.L., Aderem A., and Ravetch J.V. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J. Exp. Med. 203 (2006) 553-561
9. Frasca D., Van der Put E., Riley R.L., and Blomberg B.B. Reduced Ig class switch in aged mice correlates with decreased E47 and activation-induced cytidine deaminase. J. Immunol. 172 (2004) 2155-2162
10. Fruman D.A. Phosphoinositide 3-kinase and its targets in B-cell and T-cell signaling. Curr. Opin. Immunol. 16 (2004) 314-320
11. Fruman D.A., and Cantley L.C. Phosphoinositide 3-kinase in immunological systems. Semin. Immunol. 14 (2002) 7-18
12. Fruman D.A., Meyers R.E., and Cantley L.C. Phosphoinositide kinases. Annu. Rev. Biochem. 67 (1998) 481-507
13. Fukao T., and Koyasu S. PI3K and negative regulation of TLR signaling. Trends Immunol. 24 (2003) 358-363
14. Fukao T., Tanabe M., Terauchi Y., Ota T., Matsuda S., Asano T., Kadowaki T., Takeuchi T., and Koyasu S. PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat. Immunol. 3 (2002) 875-881
15. Gavin A.L., Hoebe K., Duong B., Ota T., Martin C., Beutler B., and Nemazee D. Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science 314 (2006) 1936-1938
16. + T cells and enables CpG oligodeoxynucleotide-mediated costimulation. Immunity 25 (2006) 783-793
17. Ishii K.J., Takeshita F., Gursel I., Gursel M., Conover J., Nussenzweig A., and Klinman D.M. Potential role of phosphatidylinositol 3 kinase, rather than DNA-dependent protein kinase, in CpG DNA-induced immune activation. J. Exp. Med. 196 (2002) 269-274
18. Iwasaki A., and Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5 (2004) 987-995
19. Kalis C., Gumenscheimer M., Freudenberg N., Tchaptchet S., Fejer G., Heit A., Akira S., Galanos C., and Freudenberg M.A. Requirement for TLR9 in the immunomodulatory activity of Propionibacterium acnes. J. Immunol. 174 (2005) 4295-4300
20. Knight Z.A., Gonzalez B., Feldman M.E., Zunder E.R., Goldenberg D.D., Williams O., Loewith R., Stokoe D., Balla A., Toth B., Balla T., Weiss W.A., Williams R.L., and Shokat K.M. A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell 125 (2006) 733-747
21. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20 (2002) 709-760
22. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., and Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374 (1995) 546-549
23. Kuhn R., Lohler J., Rennick D., Rajewsky K., and Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75 (1993) 263-274
24. Kusunoki T., Sugai M., Gonda H., Nambu Y., Nagata-Nakajima N., Katakai T., Kusunoki M., Sakamoto A., Tokuhisa T., Nakahata T., Yokota Y., and Shimizu A. CpG inhibits IgE class switch recombination through suppression of NF kappa B activity, but not through Id2 or Bcl6. Biochem. Biophys. Res. Commun. 328 (2005) 499-506
25. Lehner M.D., Morath S., Michelsen K.S., Schumann R.R., and Hartung T. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators. J. Immunol. 166 (2001) 5161-5167
26. Li M.J., Chung W., and Maizels N. Developmental specificity of immunoglobulin heavy chain switch region recombination activities. Mol. Immunol. 34 (1997) 201-208
27. Lin L., Gerth A.J., and Peng S.L. CpG DNA redirects class-switching towards "Th1-like" Ig isotype production via TLR9 and MyD88. Eur. J. Immunol. 34 (2004) 1483-1487
28. Liu N., Ohnishi N., Ni L., Akira S., and Bacon K.B. CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells. Nat. Immunol. 4 (2003) 687-693
29. Lund F.E. Cytokine-producing B lymphocytes-key regulators of immunity. Curr. Opin. Immunol. 20 (2008) 332-338
30. Martin F., Oliver A.M., and Kearney J.F. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14 (2001) 617-629
31. Martins G., and Calame K. Regulation and functions of BLIMP-1 in T and B lymphocytes. Annu. Rev. Immunol. 26 (2008) 133-169
32. Napolitani G., Rinaldi A., Bertoni F., Sallusto F., and Lanzavecchia A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 6 (2005) 769-776
33. Nashed B.F., Zhang T., Al-Alwan M., Srinivasan G., Halayko A.J., Okkenhaug K., Vanhaesebroeck B., Hayglass K.T., and Marshall A.J. Role of the phosphoinositide 3-kinase p110delta in generation of type 2 cytokine responses and allergic airway inflammation. Eur. J. Immunol. 37 (2007) 416-424
34. Ojaniemi M., Glumoff V., Harju K., Liljeroos M., Vuori K., and Hallman M. Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages. Eur. J. Immunol. 33 (2003) 597-605
35. Okkenhaug K., Bilancio A., Farjot G., Priddle H., Sancho S., Peskett E., Pearce W., Meek S.E., Salpekar A., Waterfield M.D., Smith A.J., and Vanhaesebroeck B. Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science 297 (2002) 1031-1034
36. Okkenhaug K., and Vanhaesebroeck B. PI3K in lymphocyte development, differentiation and activation. Nat. Rev. Immunol. 3 (2003) 317-330
37. Omori S.A., Cato M.H., Anzelon-Mills A., Puri K.D., Shapiro-Shelef M., Calame K., and Rickert R.C. Regulation of class-switch recombination and plasma cell differentiation by phosphatidylinositol 3-kinase signaling. Immunity 25 (2006) 545-557
38. Park Y.C., Lee C.H., Kang H.S., Chung H.T., and Kim H.D. Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, enhances LPS-induced NO production from murine peritoneal macrophages. Biochem. Biophys. Res. Commun. 240 (1997) 692-696
39. Pasare C., and Medzhitov R. Control of B-cell responses by Toll-like receptors. Nature 438 (2005) 364-368
40. Pasare C., and Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Adv. Exp. Med. Biol. 560 (2005) 11-18
41. Peng S.L. Signaling in B cells via Toll-like receptors. Curr. Opin. Immunol. 17 (2005) 230-236
42. Peng S.L., Li J., Lin L., and Gerth A. The role of T-bet in B cells. Nat. Immunol. 4 (2003) 1041 (author reply 1041)
43. Peng S.L., Szabo S.J., and Glimcher L.H. T-bet regulates IgG class switching and pathogenic autoantibody production. Proc. Natl. Acad. Sci. U S A 99 (2002) 5545-5550
44. -/-- mice: an overview. J. Leukoc. Biol. 61 (1997) 389-396
45. Rommel C., Camps M., and Ji H. PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?. Nat. Rev. Immunol. 7 (2007) 191-201
46. Sadhu C., Masinovsky B., Dick K., Sowell C.G., and Staunton D.E. Essential role of phosphoinositide 3-kinase delta in neutrophil directional movement. J. Immunol. 170 (2003) 2647-2654
47. Saegusa K., Yotsumoto S., Kato S., and Aramaki Y. Phosphatidylinositol 3-kinase-mediated regulation of IL-10 and IL-12 production in macrophages stimulated with CpG oligodeoxynucleotide. Mol. Immunol. 44 (2007) 1323-1330
48. Takeshita F., Gursel I., Ishii K.J., Suzuki K., Gursel M., and Klinman D.M. Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9. Semin. Immunol. 16 (2004) 17-22
49. Theiner G., Rossner S., Dalpke A., Bode K., Berger T., Gessner A., and Lutz M.B. TLR9 cooperates with TLR4 to increase IL-12 release by murine dendritic cells. Mol. Immunol. 45 (2008) 244-252
50. Weinstein S.L., Finn A.J., Dave S.H., Meng F., Lowell C.A., Sanghera J.S., and DeFranco A.L. Phosphatidylinositol 3-kinase and mTOR mediate lipopolysaccharide-stimulated nitric oxide production in macrophages via interferon-beta. J. Leukoc. Biol. 67 (2000) 405-414
51. Wymann M.P., and Pirola L. Structure and function of phosphoinositide 3-kinases. Biochim. Biophys. Acta 1436 (1998) 127-150
52. Zhang T.T., Okkenhaug K., Nashed B.F., Puri K.D., Knight Z.A., Shokat K.M., Vanhaesebroeck B., and Marshall A.J. Genetic or pharmaceutical blockade of p110delta phosphoinositide 3-kinase enhances IgE production. J. Allergy Clin. Immunol. 122 (2008) 811-819 e2